Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 155INDUSTRY 89NIH 30NETWORK 17OTHER_GOV 3UNKNOWN 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2NET 1Gastrointestinal 1Endocrine 1

Conditions

Small Cell Lung Carcinoma 3

Interventions

Pemetrexed 13Cisplatin 12Carboplatin 12Drug Therapy 10Gemcitabine 8Gefitinib 8Docetaxel 8camrelizumab 5apatinib 5Radiotherapy 5Paclitaxel 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Endostatins 5tislelizumab 4pembrolizumab 4endostar protein 4Simvastatin 4Bevacizumab 4anlotinib 3Platinum Compounds 3Immune Checkpoint Inhibitors 3Etoposide 3toripalimab 2surufatinib 2olaparib 2durvalumab 2atezolizumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Etoposide × Thoracic × Clear all
NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Fujian Cancer Hospital

Phase 2 Not yet recruiting
34 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03389087 2020-07-10

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

Henan Cancer Hospital

Phase 2 Unknown
60 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02738346 2016-04-25

CBPC

University Hospital, Angers

Phase 3 Unknown
164 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡